The Food and Drug Administration (FDA) closed Florida’s monoclonal antibody treatment sites on Monday after the federal government abruptly removed the treatments from Emergency Use Authorizations.The Florida Department of Health released a statement on Monday evening condemning the “abrupt” decision to take away treatments that can prevent severe illness, hospitalization, and death in high-risk patients who have contracted or been exposed to COVID-19.As a result of the @US_FDA’s abrupt decision to remove the EUAs for two monoclonal antibodies, monoclonal antibody treatment sites will be closed until further notice. Full press release is below. pic.twitter.com/RGeWTPwxCs— Florida Dept. of Health (@HealthyFla) January 25, 2022
“This evening, without any advanced notice, the US Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA)…The revised EUAs do not allow providers to administer these treatments within the United States,” the statement reads.“Unfortunately, as a result of this abrupt decision made by the federal government, all monoclonal antibody state sites will be closed until further notice…Florida disagrees with the decision that blocks access to any available treatments in the absence of clinical evidence.“The FDA is trying to make it so that people in Florida die of Covid. They’ll kill people to harm Republicans. Steel yourselves for the evil that is being unleashed. https://t.co/hP55vngVbh— Cernovich (@Cernovich) January 25, 2022
The FDA said Monday the antibody drugs from Regeneron and Eli Lilly should no longer be used because the treatments are unli …
The post FDA prohibits Florida from using monoclonal antibody treatments appeared first on Populist Press ©2022.